Impact of Fremanezumab Treatment on Clinical Outcomes Among Migraine Patients With Comorbid Depression, Anxiety or Hypertension in a Real-World Setting

被引：0
|
作者：
Tangirala, K. [1 ]
Pedarla, V. [2 ]
Driessen, M. [3 ]
Krasenbaum, L. J. [1 ]
Thompson, S. F. [1 ]
Maughn, K. [2 ]
Seminerio, M. J. [1 ]
Cohen, J. M. [1 ]
机构：
[1] Teva Branded Pharmaceut Prod R&D Inc, W Chester, PA USA
[2] STATinMED Res, Plano, TX USA
[3] Teva Pharmaceut, Amsterdam, Netherlands
来源：
JOURNAL OF HEADACHE AND PAIN | 2021年 / 22卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0314
引用
收藏
页码：114 / 114
页数：1
相关论文
共 50 条
  • [41] Treatment patterns, health resource consumption, and costs of patients with migraine in an Italian real-world setting
    Perrone, Valentina
    Veronesi, Chiara
    Giacomini, Elisa
    Andretta, Margherita
    Dell'Orco, Stefania
    De Sarro, Giovambattista
    Lena, Fabio
    Menti, Anna Michela
    Naclerio, Mariantonietta
    Ritrovato, Daniela
    Degli Esposti, Luca
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (12) : 1991 - 1998
  • [42] TREATMENT PATTERNS, HEALTH RESOURCES CONSUMPTION AND COSTS OF PATIENTS WITH MIGRAINE IN AN ITALIAN REAL-WORLD SETTING
    Perrone, V
    Veronesi, C.
    Andretta, M.
    Dell'Orco, S.
    De Sarro, G.
    Lena, F.
    Sonzogni, S.
    Naclerio, M.
    Ritrovato, D.
    Degli Esposti, L.
    VALUE IN HEALTH, 2019, 22 : S761 - S761
  • [43] US Real-world Effectiveness of Quarterly and Monthly Fremanezumab for Reducing Migraine Days and Headache Days in Adult Patients With Migraine
    Cohen, Joshua M.
    Thompson, Stephen
    Ayyagari, Rajeev
    Driessen, Maurice
    Seminerio, Michael
    Carr, Karen
    Yim, Erica
    NEUROLOGY, 2021, 96 (15)
  • [44] Real-world effectiveness and tolerability of fremanezumab for the preventive treatment of migraine in patients using concomitant gepants for acute treatment in a US neurology practice
    Eugeni, P.
    HEADACHE, 2022, 62 (07): : 927 - 927
  • [45] Real-world treatment experience and satisfaction among migraine patients: A descriptive survey study
    Smith, T. R.
    Hubig, L.
    Williams, E.
    Litalien, G. J.
    Harris, L.
    Powell, L. C.
    Johnson, K. M.
    Coric, V.
    Lloyd, A.
    Lo, S.
    HEADACHE, 2022, 62 : 82 - 83
  • [46] REAL-WORLD EFFECTIVENESS OF FREMANEZUMAB TREATMENT FOR REDUCING MONTHLY MIGRAINE AND HEADACHE DAYS IN US PATIENTS HAVING DIFFERENT NUMBERS OF PRIOR MIGRAINE PREVENTIVE TREATMENT FAILURES
    Cohen, J.
    Thompson, S.
    Sun, R.
    Driessen, M.
    Seminerio, M.
    Carr, K.
    Mu, F.
    VALUE IN HEALTH, 2022, 25 (01) : S30 - S30
  • [47] Real-world economic impact of onabotulinumtoxina in patients with chronic migraine
    JF Rothrock
    LM Bloudek
    TT Houle
    D Andress-Rothrock
    C Hanlon
    SF Varon
    The Journal of Headache and Pain, 2013, 14
  • [48] Real-World Economic Impact of OnabotulinumtoxinA in Patients with Chronic Migraine
    Rothrock, John
    Bloudek, Lisa
    Houle, Timothy
    Andress-Rothrock, Diane
    Hanlon, Christopher
    Varon, Sepideh
    NEUROLOGY, 2012, 78
  • [49] Real-World Economic Impact of OnabotulinumtoxinA in Patients With Chronic Migraine
    Rothrock, John F.
    Bloudek, Lisa M.
    Houle, Timothy T.
    Andress-Rothrock, Diane
    Varon, Sepideh F.
    HEADACHE, 2014, 54 (10): : 1565 - 1573
  • [50] Real-world economic impact of onabotulinumtoxina in patients with chronic migraine
    Rothrock, J. F.
    Bloudek, L. M.
    Houle, T. T.
    Andress-Rothrock, D.
    Hanlon, C.
    Varon, S. F.
    JOURNAL OF HEADACHE AND PAIN, 2013, 14
12345